Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids

  title={Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids},
  author={Tanya M. Teslovich and Kiran Musunuru and Albert Vernon Smith and Andrew C Edmondson and Ioannis M Stylianou and Masahiro Koseki and James P. Pirruccello and Samuli Ripatti and Daniel I. Chasman and Cristen J. Willer and Christopher T. Johansen and Sigrid W. Fouchier and Aaron Isaacs and Gina M. Peloso and Maja Barbali{\'c} and Sally L Ricketts and Joshua C. Bis and Yurii S. Aulchenko and Gudmar Thorleifsson and Mary F. Feitosa and John C Chambers and Marju Orho-Melander and Olle Melander and Toby Johnson and Xiaohui Li and Xiuqing Guo and Mingyao Li and Yoon Shin Cho and Min Jin Go and Young Jin Kim and Jong-Young Lee and Taesung Park and Kyungeun Kim and Xueling Sim and Rick Twee-Hee Ong and Damien C. Croteau-Chonka and Leslie A. Lange and Joshua D. Smith and Kijoung Song and Jing Hua Zhao and Xin Yuan and Jian’an Luan and Claudia Lamina and Andreas Ziegler and Weihua Zhang and Robert Y L Zee and Alan F. Wright and Jacqueline C. M. Witteman and James F. Wilson and Gonneke Willemsen and Heinz-Erich Wichmann and John B. Whitfield and Dawn M. Waterworth and Nicholas J. Wareham and G{\'e}rard Waeber and Peter Vollenweider and Benjamin F. Voight and Veronique Vitart and Andr{\'e} G. Uitterlinden and Manuela Uda and Jaakko Tuomilehto and John R. Thompson and Toshiko Tanaka and Ida Surakka and Heather M. Stringham and Tim D. Spector and Nicole Soranzo and Johannes H. Smit and Juha P. Sinisalo and Kaisa Silander and Eric J.G. Sijbrands and Angelo Scuteri and James G. Scott and David Schlessinger and Serena Sanna and Veikko V Salomaa and Juha Saharinen and Chiara Sabatti and Aimo O Ruokonen and Igor Rudan and Lynda M Rose and Robert Roberts and Mark J. Rieder and Bruce M. Psaty and Peter Paul Pramstaller and Irene Pichler and Markus Perola and Brenda W.J.H. Penninx and Nancy L. Pedersen and Cristian Pattaro and Alex N. Parker and Guillaume Par{\'e} and Ben A. Oostra and Christopher J. O’Donnell and Markku S Nieminen and Deborah A. Nickerson and Grant W. Montgomery and Thomas Meitinger and Ruth McPherson and Mark I. McCarthy and Wendy L McArdle and David Masson and Nicholas G. Martin and Fabio Marroni and Massimo Mangino and Patrik K. E. Magnusson and Gavin J A Lucas and Robert N. Luben and Ruth J. F. Loos and Maisa Lokki and Guillaume Lettre and Claudia Langenberg and Lenore J. Launer and Edward G. Lakatta and Reijo Laaksonen and Kirsten Ohm Kyvik and Florian Kronenberg and Inke Regina K{\"o}nig and Kay-Tee Khaw and Jaakko A Kaprio and Lee M. Kaplan and {\AA}sa Johansson and Marjo-Riitta Jarvelin and A. Cecile J. W. Janssens and Erik Ingelsson and Wilmar Igl and G Kees Hovingh and Jouke- Jan Hottenga and Albert Hofman and Andrew A. Hicks and Christian Hengstenberg and Iris M. Heid and Caroline Hayward and Aki Samuli Havulinna and Nicholas D. Hastie and Tamara B. Harris and Talin Haritunians and Alistair S. Hall and Ulf Gyllensten and Candace Guiducci and Leif C. Groop and Elena Gonzalez and Christian Gieger and Nelson B. Freimer and Luigi Ferrucci and Jeanette Erdmann and Paul Elliott and Kenechi G. Ejebe and Angela D{\"o}ring and Anna F. Dominiczak and Serkalem Demissie and Panagiotis Deloukas and Eco J. C. de Geus and Ulf de Faire and Gabriel J Crawford and Francis S. Collins and Yii-der Ida Chen and Mark J. Caulfield and Harry Campbell and Noël P. Burtt and Lori L Bonnycastle and Dorret I. Boomsma and S. Matthijs Boekholdt and Richard N. Bergman and In{\^e}s Barroso and Stefania Bandinelli and Christie M. Ballantyne and Themistocles L. Assimes and Thomas Quertermous and David M Altshuler and Mark Seielstad and Tien Yin Wong and E. Shyong Tai and Alan B. Feranil and Christopher W. Kuzawa and Linda S Adair and Herman A. Taylor and Ingrid B. Borecki and S. Gabriel and James G. Wilson and K{\'a}ri Stef{\'a}nsson and Unnur Thorsteinsd{\'o}ttir and Vilmundur G. Gudnason and Ronald M. Krauss and Karen L. Mohlke and Jos{\'e} M. Ordov{\'a}s and Patricia B. Munroe and Jaspal S Kooner and Alan R. Tall and Robert A. Hegele and John J Kastelein and Eric E. Schadt and Jerome I. Rotter and Eric Boerwinkle and David P. Strachan and Vincent Mooser and Hilma H{\'o}lm and Muredach P. Reilly and Nilesh J. Samani and Heribert Schunkert and L. Adrienne Cupples and Manjinder S. Sandhu and Paul M. Ridker and Daniel J. Rader and Cornelia M. van Duijn and Leena Peltonen and Gonçalo R. Abecasis and Michael Boehnke and Sekar Kathiresan},
  pages={707 - 713}
Plasma concentrations of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides are among the most important risk factors for coronary artery disease (CAD) and are targets for therapeutic intervention. We screened the genome for common variants associated with plasma lipids in >100,000 individuals of European ancestry. Here we report 95 significantly associated loci (P < 5 × 10−8), with 59 showing genome-wide significant association with… 

Discovery and Refinement of Loci Associated with Lipid Levels

It is found that loci associated with blood lipid levels are often associated with cardiovascular and metabolic traits, including coronary artery disease, type 2 diabetes, blood pressure, waist-hip ratio and body mass index.

Association of Genetic Variants Influencing Lipid Levels with Coronary Artery Disease in Japanese Individuals

The authors' results confirm that most of the tested lipid loci are associated with lipid traits in the Japanese, further indicating that in genetic susceptibility to lipid levels and CAD, the related metabolic pathways are largely common across the populations, while causal variants at individual loci can be population-specific.

Association of Common Genetic Variants with Lipid Traits in the Indian Population

Urban location and sex had strong interaction effects on the genetic association of most of the studied loci with lipid traits, which may explain the sex-specific differences in lipid levels and their heritability in this population.

A Genome Wide Association Study Identifies Common Variants Associated with Lipid Levels in the Chinese Population

A meta-analysis of two genome wide association studies on four common lipid traits in a Han Chinese population provided comprehensive and convincing evidence of the genetic determinants of plasma lipid levels in a Chinese population and highlighted heterogeneity in allele frequency and in effect size for some loci between Chinese and European populations.

Multiple Associated Variants Increase the Heritability Explained for Plasma Lipids and Coronary Artery Disease

A portion of the missing heritability for lipid traits and CAD can be explained by multiple variants at each locus, nearly doubling the heritability explained by genome-wide association studies.

Replication and fine-mapping of genetic predictors of lipid traits in African-Americans

The genetic architecture of lipid traits in AAs differs substantially from that in Caucasians and it remains poorly characterized.

Genetic architecture of circulating lipid levels

The results suggest that the genetic architecture of circulating lipids involves a number of undiscovered variants with very small effects, and that increasing GWAS sample sizes will enable the identification of novel variants that regulate lipid levels.

Genetics of Circulating Blood Lipids

New biology behind lipid levels is demonstrated, in addition to how large scale studies with dense SNP panels enabled by genotype imputation, can be a key in revealing biological determinants behind complex diseases and traits.

Variants discovery in the LPL and CETP genes and their associations with plasma lipid and apolipoprotein levels

Investigating the associations of both common and uncommon/rare variants in two major lipid genes, lipoprotein lipase (LPL) and cholesteryl ester transfer protein (CETP), in relation to plasma lipop protein-lipid levels in U.S. non-Hispanic whites (NHWs) and African blacks reaffirm the important role of LPL and CETP genetic variation has in affecting plasmalipoprotein-lipids levels in the general population.

Joint Influence of SNPs and DNA Methylation on Lipids in African Americans From Hypertensive Sibships

Reductions in morbidity and mortality due to variation in lipids among AAs may be achieved through a better understanding of the genetic and epigenetic factors associated with serum lipid levels for early and appropriate screening.



Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts

The first GWA analysis of loci affecting total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density cholesterol and triglycerides sampled randomly from 16 population-based cohorts and genotyped using mainly the Illumina HumanHap300-Duo platform establishes 22 loci associated with serum lipid levels at genome-wide significance level.

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

Using genome-wide association data from three studies and targeted replication association analyses in up to 18,554 independent participants, it is shown that common SNPs at 18 loci are reproducibly associated with concentrations of low-density cholesterol, high-density lipoprotein (HDL) cholesterol, and/or triglycerides.

A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study

Using a 100K genome-wide scan, a set of putative associations for common sequence variants and lipid phenotypes are generated using a three-stage replication strategy of the GEE association results with no convincing statistical evidence for association between any of the tested SNPs and lipid phenotype.

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

To identify genetic variants influencing plasma lipid concentrations, we first used genotype imputation and meta-analysis to combine three genome-wide scans totaling 8,816 individuals and comprising

Common variants at 30 loci contribute to polygenic dyslipidemia

The results suggest that the cumulative effect of multiple common variants contributes to polygenic dyslipidemia.

Genome-wide association analysis of metabolic traits in a birth cohort from a founder population

The association observed between low-density lipoprotein and an infrequent variant in AR suggests the potential of such a cohort for identifying associations with both common, low-impact and rarer, high-impact quantitative trait loci.

Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels

The discovery of associated variants in unsuspected genes and outside coding regions illustrates the ability of genome-wide association studies to provide potentially important clues to the pathogenesis of common diseases.

Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis

While conventional LDL-C, HDL-C, and triglyceride measurements reflect aggregate properties of plasma lipoprotein fractions, NMR-based measurements more accurately reflect lipoprotein particle

From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus

Functional evidence for a novel regulatory pathway for lipoprotein metabolism is provided and it is suggested that modulation of this pathway may alter risk for MI in humans.